The Issuer clarified disclosure related to its corporate presentation and website to include the name of the qualified person, revise disclosure related to a historical estimate, remove a third party research report, and remove a non-compliant fact sheet.

The Issuer filed a registration statement on Form S-1 with the United States Securities and Exchange Commission that included December 31, 2021 annual financial statements prepared in accordance with US GAAP. The Issuer’s subsequent continuous disclosure filings on SEDAR incorporate by reference the US GAAP financial statements included in the registration statement, which had not been filed on SEDAR pursuant to item 11.1 of National Instrument 51-102. The Issuer filed the Registration Statement, inclusive of the US GAAP Annual Statements, on SEDAR.

The Issuer has amended and restated the previously filed audited financial statements for the financial year ended March 31, 2022 in addressing Staff’s comments from a continuous disclosure review. Part 3.2 of Companion Policy 51-102CP Continuous Disclosure Obligations states that when an issuer changes its auditors during the periods presented in the annual financial statements and the new auditor has not audited the comparative period, the auditor’s report would normally refer to the predecessor auditor’s report unless that predecessor auditor’s report on the comparative period is reissued with the financial statements. As the new auditor’s report did not refer to the predecessor auditor’s report, the amended and restated financial statements therefore include the predecessor auditor’s report, covering the financial year ended March 31, 2021.

The issuer filed executive compensation disclosure that was required to be filed at an earlier date.

The Issuer refiled its financial statements and MD&A for the interim period ended June 30, 2022 to correct the Statements of Cash Flows, which (1) erroneously referred to the current and comparative periods disclosed as “December 31, 2022 and 2021” instead of “June 30, 2022 and 2021”; and (2) presented the incorrect financial information for the comparative period. The Q2 2022 MD&A was also revised to correct commentary related to the Statements of Cash Flows, reflecting changes to the financial information for the 2021 comparative period presented in the revised Q2 2022 financial statements, and an erroneous reference to “the three months ended March 31, 2022”, which should refer to the “the six months ended June 30, 2022”

Technical disclosure in news release (August 22, 2022) did not comply with NI 43-101 (deficiency 2d)

The Issuer clarified its disclosure related to the July 25, 2022 news release regarding the Mont Sorcier Iron and Vanadium Project to indicted that the PEA technical report filed on September 8, 2022 was completed by QPs that are all independent of the Issuer and the PEA was completed using only indicated mineral resources.

NI 43-101 technical report disclosure (deficiency 2d)

Reasons for Refilings: The Company amended and refiled its March 31, 2022 and December 31, 2021 Management Discussion and Analysis (“MD&A”) to enhance disclosure relating to, among other things, COVID-19 impacts, current projects of the Company and their status, overall performance, and discussions of operations, including its SponsorCoin Platform and the Hemp products and Vitamin Shots marketplace and the Ready to Drink (“RTD”) spirits and premium spirits, transactions between related parties, and liquidity and cash resources. The Company has also enhanced its disclosure regarding the regulatory framework relating to regulated Hemp and Alcohol products in each jurisdiction where the Company operates. The Company also filed a material change report regarding the appointment of Charles Sung as the CFO on March 9, 2022.

The website of CI Investments Inc. included certain included statements about the application of its Responsible Investment Policy and the consideration of ESG factors as part of the investment process for the funds that it manages. Revisions to the website were made to clarify that the Responsible Investing Policy of CI Investments Inc. does not apply to certain funds that it manages.

The Issuer re-filed an: (a) amended and restated management's discussion and analysis (the "A&R MD&As") related to its annual consolidated financial statements for the years ended February 28, 2023 and February 28, 2022, and the interim period ended May 31, 2023, (b) amended and restated annual information form for the year ended February 28, 2023 (the "A&R AIF"), and (c) amended and restated Form 51-102F6V Statement of Executive Compensation for the year ended February 28, 2023 (the "A&R Form51-102F6V" and together, the "A&R Annual Filings").

In the A&R MD&As, the Company has made certain corrective disclosures in respect of the Company's business, operations, projects, the impact of COVID-19 on the Company, related party transactions, capital expenditure commitments and known trends or expected fluctuations in the Issuer's financial resources and sources of financing that have been arranged but not yet used, breakdown of material expenses, including consulting fees and share based compensation, objectives and milestones as required under Form 51-102F1 Management's Discussion and Analysis.

The A&R AIF has been amended to reflect the Company's September 11, 2023 technical report with respect to its material property, the Lac a L'Orignal project. Finally, the A&R Form 51-102F6V was amended to correct share based compensation made to certain directors and officers that was previously omitted in the management information circular dated July 25, 2023 to include corrective disclosure providing additional details and clarifications with respect to the Issuer’s current business operations, prior news releases, revenues and direct costs, variations in financial reporting, and liquidity as required under Form 51-102F1 Management’s Discussion and Analysis.

The Issuer re-filed its management’s discussion and analysis (“MD&A”) for the year ended December 31, 2022, and for the period ended March 31, 2023, to include corrective disclosure providing additional details and clarifications with respect to the Issuer’s current business operations, prior news releases, revenues and direct costs, variations in financial reporting, and liquidity as required under Form 51-102F1 Management’s Discussion and Analysis. As a result of the corrective disclosure re-filings the Issuer also re-filed certifications of interim and annual filings for each MD&A in compliance with National Instrument 52-109 Certification of Disclosure in Issuers’ Annual and Interim Filings.